# Appendix C — Target Account Profile (TAP)

Use this to qualify whether an account belongs on the target list:

- [ ] Pharma/biotech with 3+ active clinical programs
- [ ] Has pharmacovigilance or benefit-risk function
- [ ] Currently doing BRA manually (Excel, Word, consultants)
- [ ] Budget authority at VP/Director level accessible
- [ ] In a therapeutic area where we have/are building disease-specific versions
- [ ] Annual R&D budget >$50M (mid-market) or >$500M (enterprise)

**If 5 of 6 boxes checked → add to target list. If <4 → pass.**

*Extracted from ArcaScience OKR Execution Blueprint — Appendix*
